This bill matters because it aims to protect people from potentially dangerous or ineffective products that are currently sold as dietary supplements. Some products, which may have drug-like effects or be addictive, are marketed as supplements to bypass stricter drug regulations, putting consumers at risk. Tianeptine, a substance with opioid-like effects, is an example of such a product.

If this bill becomes law, consumers could have more confidence that products labeled as dietary supplements are actually what they claim to be and haven't been made with the involvement of individuals with a history of violating safety rules. This could lead to a cleaner, safer supplement market. If it doesn't pass, the problem of mislabeled or questionably produced supplements could continue, leaving consumers vulnerable to health risks and deceptive marketing practices.